Regeneron Pain Drug Put On Clinical Hold By FDA

BOSTON - Regeneron Pharmaceuticals Inc said on Monday that U.S. regulators placed the company's experimental pain drug for osteoarthritis on clinical hold after a patient in another company's trial developed a serious bone disorder.